Delta-Fly Pharma: Notice regarding completion of exercise of the 8th Stock Acquisition Rights (Stock Acquisition Rights with Exercise Price Amendment Clauses) and monthly exercise status
Delta-Fly Pharma: Notice Concerning Mass Exercise of the 8th Stock Acquisition Rights (Stock Acquisition Rights with Exercise Price Amendment Clauses)
Delta-Fly Pharma: Notice regarding clinical trial status of DFP-10917+VEN+ and DFP-10917
Delta-Fly Pharma: Notice regarding the development status of DFP-17729
Delta-Fly Pharma: Notice regarding the monthly exercise status of the 8th Stock Acquisition Rights (Stock Acquisition Rights with Exercise Price Amendment Clauses)
Delta-Fly Pharma: Notice Concerning Mass Exercise of the 8th Stock Acquisition Rights (Stock Acquisition Rights with Exercise Price Amendment Clauses)
Delta-Fly Pharma: Notice regarding the clinical phase 3 comparative trial of DFP-14323
Delta-Fly Pharma: Notice regarding responses to inquiries
Delta-Fly Pharma: Progress of the DFP-14927 Expanded Clinical Phase 1 Trial
Delta-Fly Pharma: Notice regarding the monthly exercise status of the 8th Stock Acquisition Rights (Stock Acquisition Rights with Exercise Price Amendment Clauses)
Delta-Fly Pharma: Notice Concerning Mass Exercise of the 8th Stock Acquisition Rights (Stock Acquisition Rights with Exercise Price Amendment Clauses)
Delta-Fly Pharma: Notice Concerning Mass Exercise of the 8th Stock Acquisition Rights (Stock Acquisition Rights with Exercise Price Amendment Clauses)
Delta-Fly Pharma: Notice regarding the progress of the DFP-10917 and VEN clinical phase 1/2 trials
Delta-Fly Pharma: Notice Concerning Mass Exercise of the 8th Stock Acquisition Rights (Stock Acquisition Rights with Exercise Price Amendment Clauses)
Delta-Fly Pharma: Notice Concerning Changes in Major Shareholders
Delta-Fly Pharma: Notice Concerning Changes in Major Shareholders
Delta-Fly Pharma: Notice regarding commencement of case registration for clinical phase 1/2 trials of DFP-10917 and VEN
Delta-Fly Pharma: Announcements of individual stocks regarding the start of clinical phase 3 comparative trial case registration for DFP-14323.
Delta-Fly Pharma: Independent Company Executives Declaration
Delta-Fly Pharma: Matters related to business plans and growth potential.
No Data